甜食
发表于 2025-3-28 18:10:12
http://reply.papertrans.cn/24/2304/230370/230370_41.png
凌辱
发表于 2025-3-28 19:32:59
Ioannis K. Vlachos,George D. Sergiadiss need to be based on a fair balance of relevant ethical norms and values. In this chapter, an ethical perspective on medicinal product risk communication will be introduced and four areas of ethical tension and the contexts of uncertainty and trust are discussed, which should be taken into account
委派
发表于 2025-3-29 01:03:59
http://reply.papertrans.cn/24/2304/230370/230370_43.png
Guileless
发表于 2025-3-29 06:35:36
http://reply.papertrans.cn/24/2304/230370/230370_44.png
APO
发表于 2025-3-29 08:48:30
http://reply.papertrans.cn/24/2304/230370/230370_45.png
rectocele
发表于 2025-3-29 15:25:30
Communicating about Risks and Safe Use of Medicines978-981-15-3013-5
被告
发表于 2025-3-29 19:19:13
http://reply.papertrans.cn/24/2304/230370/230370_47.png
MAIM
发表于 2025-3-29 20:02:23
A Multilayered Research Framework for Humanities and Epidemiology of Medicinal Product Risk Communi and deeper understanding of the complexity of communication as well as the causal relationships, risk and success factors and pathways towards outcomes. This research approach advocates for the active participation of patients, healthcare professionals and journalists in research and mutual learnin
Hamper
发表于 2025-3-30 01:03:54
http://reply.papertrans.cn/24/2304/230370/230370_49.png
jet-lag
发表于 2025-3-30 04:45:37
http://reply.papertrans.cn/24/2304/230370/230370_50.png